Tesamorelin is a synthetic GHRH (growth hormone-releasing hormone) analog that stimulates natural HGH release. It is commonly used for visceral fat reduction, muscle preservation, recovery, and metabolic support.
Targets visceral and abdominal fat
Helps preserve lean muscle mass
Supports metabolism and energy production
May improve recovery and nerve regeneration
Supports cognitive and metabolic function
Usually mild:
Injection site irritation
Headache
Muscle aches
Nausea
Sweating
Fluid retention
Less common:
Carpal tunnel symptoms
Tingling or numbness
Elevated blood sugar
Rare but serious:
Severe GI symptoms
Shortness of breath
Diabetes risk increase
Tesamorelin may raise blood sugar levels.
Use caution when combining with:
Tirzepatide
Other diabetes medications
Do not use if:
Pregnant or breastfeeding
Active cancer
Pituitary disorders or tumors
History of hypothalamic-pituitary disruption
Allergic to mannitol
Subcutaneous injection
Cycle length: 12 to 16 weeks
Washout: 4 to 8 weeks
Dose 5 days weekly with 2 rest days
Best taken at night
Inject at least 90 minutes after eating
Store at room temperature in a cool, dry, dark location
Avoid refrigeration when possible to reduce gelling
Mix:
10mg vial + 2.5mL (250 units) BAC water
25 units (1mg)
Once daily
5 days weekly
50 units (2mg)
Once daily
5 days weekly
Mix:
20mg vial + 3mL (300 units) BAC water
15 units (1mg)
Once daily
5 days weekly
30 units (2mg)
Once daily
5 days weekly
AOD-9604 for abdominal fat support
CJC-1295 + Ipamorelin for HGH and recovery support
GHK-Cu for skin and collagen support
MOTS-C for metabolic enhancement
SS-31 for mitochondrial support
L-Carnitine for fat metabolism and energy